Exact Sciences
EXAS
EXAS was delisted on the 20th of March, 2026.
472 hedge funds and large institutions have $13.5B invested in Exact Sciences in 2019 Q2 according to their latest regulatory filings, with 104 funds opening new positions, 142 increasing their positions, 148 reducing their positions, and 51 closing their positions.
104% more first-time investments, than exits
New positions opened: 104 | Existing positions closed: 51
39% more capital invested
Capital invested by funds: $9.77B → $13.5B (+$3.77B)
25% more funds holding in top 10
Funds holding in top 10: 8 → 10 (+2)
11% more funds holding
Funds holding: 424 → 472 (+48)
0.73% less ownership
Funds ownership: 89.66% → 88.93% (-0.73%)
4% less repeat investments, than reductions
Existing positions increased: 142 | Existing positions reduced: 148
54% less call options, than puts
Call options by funds: $284M | Put options by funds: $612M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
+$265M |
| 2 |
Jennison Associates
New York
|
+$228M |
| 3 |
JP Morgan Chase
New York
|
+$201M |
| 4 |
BlackRock
New York
|
+$128M |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
+$107M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Primecap Management
Pasadena,
California
|
-$122M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$112M |
| 3 |
Viking Global Investors
Stamford,
Connecticut
|
-$95.8M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$92.3M |
| 5 |
D.E. Shaw & Co
New York
|
-$87M |
EXAS Hedge Fund Activity: Q2 2019 in Review
472 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in Exact Sciences (EXAS) for Q2 2019, worth a combined $13.5B — up 39% from $9.77B a quarter earlier.
Buyers outnumbered sellers: 104 funds opened new EXAS positions and 51 closed out — a net gain of 53 holders — while 142 added to existing stakes and 148 trimmed.
The largest buyer was Invesco, adding an estimated $265M. The largest seller was Primecap Management, cutting an estimated $122M.
- 472 institutional investors held Exact Sciences (EXAS) as of Q2 2019, up from 424 in Q1 2019.
- Funds reported $13.5B of Exact Sciences stock for Q2 2019, up 39% quarter-over-quarter.
- 104 funds opened new Exact Sciences positions in Q2 2019 and 51 closed out, a net change of +53 holders.
- The largest Exact Sciences buyer in Q2 2019 was Invesco, an estimated $265M added.
- The largest Exact Sciences seller in Q2 2019 was Primecap Management, an estimated $122M sold.
Based on aggregated 13F filings for Q2 2019.